Advertisement
Medtronic
Subscribe to Medtronic

The Lead

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014 12:10 pm | by The Associated Press | News | Comments

Medtronic, Inc. has announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including patient mortality and hospitalizations - in heart failure patients who have cardiac resynchronization...

Medtronic Acquires NGC Medical to Strengthen Its Integrated Health Solutions Portfolio

August 27, 2014 9:16 am | by The Associated Press | News | Comments

Medtronic, Inc. has announced that it has completed the acquisition of NGC Medical S.p.A. (NGC...

Medtronic Acquires Sapiens Steering Brain Stimulation

August 26, 2014 12:08 pm | by Medtronic, Inc. | News | Comments

Medtronic, Inc. today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens...

Medtronic’s Viva Cardiac Resynchronization Therapy-Pacemaker Approved in U.S.

August 25, 2014 10:26 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the U.S. Food and Drug Administration (FDA) approval of its newest...

View Sample

FREE Email Newsletter

Tax Savings Not Only Benefit to Medtronic-Covidien Deal

August 19, 2014 10:37 am | by The Associated Press | News | Comments

US-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two of the world's biggest medical device makers and helping Medtronic savings with a headquarters change.  Kalorama estimates the deal will come...

FDA Approval for Medtronic’s Attain Performa Quadripolar Lead and Viva Quad CRT-Ds

August 7, 2014 9:47 am | by Medtronic | News | Comments

Medtronic, Inc. has announced it has received United States Food and Drug Administration (FDA) approval for the Attain Performa Model 4298 quadripolar lead, and the Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators...

Medtronic Launches NuVent EM Sinus Dilation System for Fusion ENT Navigation System

August 4, 2014 8:36 am | by Medtronic | News | Comments

Medtronic Inc. has announced the launch of the NuVent EM Sinus Dilation System for the Fusion ENT Navigation System, developed and manufactured by the company's Ear Nose and Throat (ENT) division of its Surgical Technologies business. NuVent...

Advertisement

Infographic: Insulin Pumps Beat Injections in Type 2 Diabetes Management

July 7, 2014 11:17 am | by Medtronic | News | Comments

In the OpT2mise trial, those using insulin pumps achieved a mean A1C (average blood glucose) reduction of 1.1 percent compared to only a 0.4 percent reduction by those using multiple daily injections. This improvement in glucose control was...

Type 2 Diabetes Patients Achieve Superior Outcomes with Insulin Pumps vs. Multiple Daily Injections

July 7, 2014 11:17 am | by Medtronic | News | Comments

As an example of its commitment to improving clinical outcomes for all people with diabetes, Medtronic, Inc. has announced the results of the OpT2mise trial, which showed that MiniMed insulin pumps safely achieve better glucose control for...

This Rainbow Leads to New Medical Innovations

June 27, 2014 2:45 pm | by Bloomberg | Videos | Comments

Efi Cohen-Arazi, co-founder and Chief Executive Officer at Rainbow Medical, talks with Elliott Gotkine about innovations to help those who have lost their vision and their partnership with Medtronic on a nerve stimulation product. He speaks...

Insertable Cardiac Monitors Detect Afib in Stroke Patients Better Than Standard Care

June 26, 2014 9:34 am | by Medtronic | News | Comments

Medtronic Inc. has announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) Clinical Trial have been published in The New England Journal of Medicine. The Trial found that continuous cardiac monitoring...

GlobalData Analysts: Strategic Benefits, Not Tax Avoidance, the Main Motivation for Medtronic Megadeal

June 24, 2014 2:08 pm | by GlobalData | News | Comments

Medtronic’s $42.9 billion merger with Covidien, which created last week the world’s largest medical devices company, was primarily motivated by future market gains rather than tax inversion, according to analysts with research and consulting...

Advertisement

Medtronic Announces Preliminary Outcomes for World’s Smallest Cardiac Pacemaker

June 19, 2014 2:48 pm | by Medtronic | News | Comments

Medtronic, Inc. has announced preliminary results from the first human implants of the world’s smallest pacemaker, the Micra Transcatheter Pacing System (TPS). Results from the first four patients to receive the Micra TPS were reported at...

Tax Savings Not Only Benefit to Medtronic-Covidien Deal

June 18, 2014 3:53 pm | by Kalorama | News | Comments

U.S.-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two of the world’s biggest medical device makers and helping Medtronic savings with a headquarters change. Kalorama estimates the deal will come...

Medtronic to Buy Covidien

June 16, 2014 9:10 am | by Josh Boak, AP Business Writer | News | Comments

U.S. medical device manufacturer Medtronic has agreed to buy Ireland-based competitor Covidien for $42.9 billion in cash and stock. The combined company would have its executive offices in Dublin, where it could benefit from Ireland's lower...

Medtronic Heart Valve Approved for Broader Use

June 13, 2014 11:14 am | by The Associated Press | News | Comments

Medtronic Inc. said Thursday that the FDA approved its artificial heart valve, CoreValve, for use in more patients who face serious risks from open-heart surgery, the standard treatment. Medtronic's implant is a less invasive approach to...

World's First Combined Glucose Sensor and Insulin Infusion Set for Diabetics Launches

June 3, 2014 10:37 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the European launch of MiniMed Duo, the world's first two-in-one breakthrough that combines a glucose sensor and insulin infusion set into one on-body device, simplifying integrated insulin pump therapy and...

Advertisement

Medtronic Unveils Online Community to Connect People with Medical Devices Who ‘Live On. Give On.’

June 2, 2014 11:24 am | by Medtronic | News | Comments

Medtronic, Inc. today opened 2014 award applications for the Bakken Invitation, a global program designed to celebrate and connect people who, with the help of medical technology, have overcome health challenges and are now selflessly giving...

Medtronic Launches Advisa and Ensura SR MRI SureScan Pacemaker Systems in Europe

June 2, 2014 10:22 am | by Medtronic | News | Comments

Medtronic, Inc., today announced CE (Conformité Européenne) Mark and commercial launch of the Advisa and Ensura SR MRI SureScan single chamber pacemaker devices in Europe. Both pacemakers are approved for magnetic resonance imaging (MRI)...

Report on Medical Device Market Outlines Challenges, Opportunities for Cost Containment

May 30, 2014 3:44 pm | by Rich Gedney, CEO, ADMET | Admet, Inc. | Blogs | Comments

The medical device market has experienced tremendous growth, reaching more than $330 billion worldwide. While the industry remains healthy, several challenges face those who design and manufacture medical devices. ADMET serves this market...

Medtronic Settles Whistleblower Lawsuit for $9.9M

May 29, 2014 3:19 pm | by The Associated Press | News | Comments

Medical device maker Medtronic Inc. will pay the U.S. Department of Justice $9.9 million to settle a lawsuit that accused the company of giving doctors gifts in return for using its defibrillators and pacemakers. Medtronic has not admitted...

Understanding and Treating Networks of the Brain

May 27, 2014 10:49 am | by DARPA | News | Comments

Work on DARPA’s Systems-Based Neurotechnology for Emerging Therapies (SUBNETS) program is set to begin with teams led by UC San Francisco (UCSF), and Massachusetts General Hospital (MGH). The SUBNETS program seeks to reduce the severity...

Photos of the Day: Treating Neuropsychological Illness in Vets

May 27, 2014 10:48 am | by DARPA | News | Comments

UCSF and MGH will oversee teams of physicians, engineers, and neuroscientists who are working together to develop advanced brain interfaces, computational models of neural activity, and clinical therapies for treating networks of the brain...

CoreValve System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study

May 21, 2014 2:19 pm | by Medtronic Inc. | News | Comments

Medtronic, Inc. today revealed new data showing that patients treated with the CoreValve System experienced positive clinical outcomes in the rigorous "real world" Medtronic CoreValve ADVANCE Study. Presented at EuroPCR 2014, the transcatheter...

Medtronic Announces CE Mark and Launch of NC Euphora Coronary Balloon

May 20, 2014 10:26 am | by Medtronic | News | Comments

Continuing its commitment to bringing advanced and clinically relevant interventional technologies to market, Medtronic, Inc. has announced CE (Conformité Européene) mark and launch of the NC Euphora Noncompliant Balloon Dilatation Catheter...

Medtronic Settles Global Patent Litigation with Edwards Lifesciences

May 20, 2014 9:37 am | by Medtronic | News | Comments

Medtronic, Inc. announced that it has reached a global patent settlement agreement with Edwards Lifesciences Corporation. Under the terms of the cross-license settlement agreement, the parties will dismiss all of the pending litigation matters...

Pacemaker Algorithm Significantly Delays Atrial Fibrillation

May 12, 2014 9:48 am | by Medtronic Inc. | News | Comments

New data presented as a late-breaking clinical trial at the Heart Rhythm Society's 2014 Annual Scientific Sessions show that an advanced pacing feature exclusive to Medtronic, Inc. pacemakers significantly delays the progression of persistent...

Medtronic ICDs Safely Extend Detection Times for Secondary Prevention Patients

May 12, 2014 9:38 am | by Medtronic Inc. | News | Comments

Medtronic, Inc. today announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter defibrillators (ICDs) can safely extend detection times before triggering therapy in secondary...

Study: Promising Results with Novel Approach to Medtronic Cardiac Resynchronization Therapy

May 9, 2014 2:02 pm | by Medtronic | News | Comments

Medtronic, Inc. today released study findings that show heart failure patients who have limited options for implanted device therapy may benefit from a novel implant technique for cardiac resynchronization therapy (CRT) devices. Data from...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading